Our data showed that high FDFT1 expression predicts better prognoses for patients with CRC in the Fudan University Shanghai Cancer Center (FUSCC) cohort (P = 0.0238, log-rank test) (Fig. 2i). The gene discussed is FDFT1; the disease is colorectal carcinoma.